10.46243/jst.2021.v6.i04.pp292-301 registered
Design and In-vivo Assessment of Quercetin-Based Nanosponges Buccal Quercetin Tablets
Resolves to https://www.jst.org.in/index.php/pub/article/view/650
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2021.v6.i04.pp292-301
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 deb3e1af544b0529…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Design and In-vivo Assessment of Quercetin-Based Nanosponges Buccal Quercetin Tablets (PrincipalTitle · en)
Published 2021-07-27
Part of Journal of Science & Technology · ISSN 2456-5660 · volume 06 · issue 04 · pages 292–301
Agents
- Dr.Ratnasree (author)
- Dr.Rafia (author)
- Shivaprasad (author)
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2021.v6.i04.pp292-301
Abstract · en
The goal was to use cyclodextrin-based nanosponges to create a controlled release formulation that would boost quercetin's bioavailability. Using the freeze-drying method, a 3-factor, 3-level Box-Behnken design containing quercetin was loaded into nanosponges based on the results of preliminary testing. After being manufactured, characterized, and formed into tablets, the prepared nanosponges were inspected. The drug release percentages at six hours range from 53.04 to 82.64% for the quercetin-loaded nanosponges, whereas the particle sizes range from 36.45 to 135.27 nm and the encapsulation efficiencies from 42.37 to 88.44%. The Quercetin-nanosponge interaction was confirmed by FTIR, DSC, and XRD analyses. After the nanosponges were converted into tablets, the medication released from them at a rate of 99.75% in vitro, and stability tests revealed no appreciable alterations six months later. Rats were used in in vivo investigations to compare the Cmax of quercetin optimized nanosponges tablets (6.27 ± 0.06 ng/mL) to the Cmax of the pure medication (3.07 ± 0.086 ng/mL), which was substantially lower (p<0.05). The Tmax values for the pure drug solution and the nanosponges tablet formulation were 0.5 ± 0.08 h and 4.0 ± 0.07 h, respectively.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2021.v6.i04.pp292-301 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Design and In-vivo Assessment of Quercetin-Based Nanosponges Buccal Quercetin Tablets (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | author: Dr.Ratnasree author: Dr.Rafia author: Shivaprasad publisher: Longman Publishers published: 2021-07-27 part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 06 · no. 04 · pp. 292–301 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2026-09-10 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 7 references; 7 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 Hollman PC, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol. 1999; 37:937–942 | 10.1016/s0278-6915(99)00079-4 | not held here |
| 2 | ref2 Chen-yu G, Chun-fen Y, Qi-lu L et al. Development of a quercetinloaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm. 2012; 430:292–298 | 10.1016/j.ijpharm.2012.03.042 | not held here |
| 3 | ref3 Kumari A, Yadav SK, Pakade YB, Singh B, Yadav SC. Development of biodegradable nanoparticles for delivery of quercetin. Coll Surf B Biointer. 2010; 80:184–192 | 10.1016/j.colsurfb.2010.06.002 | not held here |
| 4 | ref4 Kaur, Simranjot & Kumar, Sandeep. The Nanosponges: An Innovative Drug Delivery System. Asian J Pharm Chem Res. 2019; 12:60-67 | 10.22159/ajpcr.2019.v12i7.33879 | not held here |
| 5 | ref5 Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of itraconazole. J Inc Phenom Macrocycl Chem. 2007; 57:89-94. Page | 300 | 10.1007/s10847-006-9216-9 | not held here |
| 6 | ref6 Swaminathan S, Pastero L, Serpe L, Trotta F, Vavia P, Aquilano D, Trotta M, Zara G, Cavalli R. Cyclodextrinbased nanosponges encapsulating camptothecin: physicochemical characteri… | 10.1016/j.ejpb.2009.11.003 | not held here |
| 7 | ref7 Anandam S, Selvamuthukumar S. Fabrication of cyclodextrin n a no s p on g e s f or quer c e t i n del i ver y : phy s ic o c hem ic a l characterization, photostability, and antio… | 10.1007/s10853-014-8523-6 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 83 fields set · sha256 2d43a88eb348… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.
Changes made at Crossref through DOI Doctor
Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.
| When | What changed | Crossref | Fingerprint |
|---|---|---|---|
| 11 Sep 2026, 05:17 | Address updated from https://www.jst.org.in/index.php/pub/article/view/650/581 to https://www.jst.org.in/index.php/pub/article/view/650 | ● accepted by Crossref | f8009f83bed6… |
| 12 Sep 2026, 01:39 | Licence added https://creativecommons.org/licenses/by/4.0 | ● accepted by Crossref | b16f8c1e06a2… |
| 13 Sep 2026, 01:40 | Read back: the DOI resolves to the new address | ● confirmed | 21ddbe897275… |
| 21 Sep 2026, 00:54 | Metadata completed publication date | ● waiting for Crossref's answer | 7e3bf81d566e… |
| 21 Sep 2026, 01:45 | Read back: Crossref's record shows it | ● confirmed | 183c4b295744… |
5 entries · the last fingerprint 183c4b295744d28239ce9645bc818de70e25ffe8191766817905dd57de045e5a · the history as JSON, each entry with the fingerprint before it, to check them yourself.



